Treating Ishikawa cells with BenzylN-acetyl-·-galactosaminide and tunicamycin induced an increase in the adhesion ability of the cells, and reduced the binding of alpha2beta1 integrin and MUC1, inhibiting tumor growth and migration [28]. The gene discussed is MUC1; the disease is neoplasm.